Dry AMD & GA IME Platform: Understanding Emerging Treatment Approaches for dry AMD and Geographic Atrophy
1 September, 13:15 – 14:15 CEST
Hall 3
Chairperson(s): F. Holz GERMANY
Photobiomodulation Preclinical Mechanisms to Clinical Application: US Pivotal LIGHTSITE III Trial Results in Intermediate dry AMD Patients
1 September, 13:15 – 14:15 CEST
Hall G1
Chairperson(s): M. Munk AUSTRIA